(Q38534294)

3 September 2017

1 reference

title

The importance of the tumor microenvironment in the therapeutic management of cancer (English)

1 reference

3 September 2017

4

Rémi Longuespée

0 references

author name string

Charles Pottier

1

1 reference

3 September 2017

Alodie Wheatherspoon

2

1 reference

3 September 2017

Patrick Roncarati

3

1 reference

3 September 2017

Michael Herfs

5

1 reference

3 September 2017

Anaelle Duray

6

1 reference

3 September 2017

Philippe Delvenne

7

1 reference

3 September 2017

Pascale Quatresooz

8

1 reference

3 September 2017

publication date

22 June 2015

1 reference

Expert Review of Anticancer Therapy

3 September 2017

published in

1 reference

3 September 2017

volume

15

1 reference

3 September 2017

issue

8

1 reference

3 September 2017

page(s)

943-954

1 reference

Molecular pathways: involving microenvironment damage responses in cancer therapy resistance

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

The split nature of tumor-infiltrating leukocytes: Implications for cancer surveillance and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

M2-polarized tumor-associated macrophages are associated with poor prognoses resulting from accelerated lymphangiogenesis in lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

Macrophages in tumor microenvironments and the progression of tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

Th9 cells: a novel CD4 T-cell subset in the immune war against cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

Myeloid derived suppressor cells - a new therapeutic target in the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

Increase in CD14+HLA-DR -/low myeloid-derived suppressor cells in hepatocellular carcinoma patients and its impact on prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

Imaging tumor-stroma interactions during chemotherapy reveals contributions of the microenvironment to resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

Plasmacytoid dendritic cells and their therapeutic activity in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

Pancreatic cancer stroma: understanding biology leads to new therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

Main features of human T helper 17 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

Robust Antitumor Effects of Combined Anti-CD4-Depleting Antibody and Anti-PD-1/PD-L1 Immune Checkpoint Antibody Treatment in Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

Depleting tumor-specific Tregs at a single site eradicates disseminated tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

Regulatory T cell subsets in human cancer: are they regulating for or against tumor progression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

Regulatory (FoxP3+) T-cell tumor infiltration is a favorable prognostic factor in advanced colon cancer patients undergoing chemo or chemoimmunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

Impaired function of CD4+ T follicular helper (Tfh) cells associated with hepatocellular carcinoma progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

Six-of-the-best: unique contributions of γδ T cells to immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

Capturing and characterizing immune cells from breast tumor microenvironment: an innovative surgical approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

Neutrophil-lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

IFN-γ-driven intratumoral microenvironment exhibits superior prognostic effect compared with an IFN-α-driven microenvironment in patients with colon carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

The STING pathway and the T cell-inflamed tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

Innate and adaptive immune cells in the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

Towards the introduction of the 'Immunoscore' in the classification of malignant tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

Angiogenesis in spontaneous tumors and implications for comparative tumor biology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

Tumour vasculogenic mimicry is associated with poor prognosis of human cancer patients: a systemic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

Lymphatic microvessel density and vascular endothelial growth factor-C and -D as prognostic factors in breast cancer: a systematic review and meta-analysis of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

VEGF-C expression is associated with the poor survival in gastric cancer tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

Accessories to the crime: functions of cells recruited to the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

The tumor microenvironment at a glance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

Expression changes in the stroma of prostate cancer predict subsequent relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

VEGF levels and the angiogenic potential of the microenvironment can affect surgical strategy for colorectal liver metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

A positive-margin resection model recreates the postsurgical tumor microenvironment and is a reliable model for adjuvant therapy evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

Chemotherapy alters monocyte differentiation to favor generation of cancer-supporting M2 macrophages in the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

PGE(2)-driven induction and maintenance of cancer-associated myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

Antitumor effect of paclitaxel is mediated by inhibition of myeloid-derived suppressor cells and chronic inflammation in the spontaneous melanoma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

B cells regulate macrophage phenotype and response to chemotherapy in squamous carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

Chemoimmunotherapy: reengineering tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

Tumour-microenvironment interactions: role of tumour stroma and proteins produced by cancer-associated fibroblasts in chemotherapy response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

Initial modulation of the tumor microenvironment accounts for thalidomide activity in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

Suppression of Aggrus/podoplanin-induced platelet aggregation and pulmonary metastasis by a single-chain antibody variable region fragment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

Boosting the MHC Class II-Restricted Tumor Antigen Presentation to CD4+ T Helper Cells: A Critical Issue for Triggering Protective Immunity and Re-Orienting the Tumor Microenvironment Toward an Anti-Tumor State

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

The convergence of radiation and immunogenic cell death signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

Radiation and immunotherapy: a synergistic combination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

Immunologically augmented cancer treatment using modern radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

In situ observation of the effects of local irradiation on cytotoxic and regulatory T lymphocytes in cervical cancer tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

The interaction of anticancer therapies with tumor-associated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

Expression of NF-κB p50 in tumor stroma limits the control of tumors by radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

Combination of lentivector immunization and low-dose chemotherapy or PD-1/PD-L1 blocking primes self-reactive T cells and induces anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

Enhanced cancer radiotherapy through immunosuppressive stromal cell destruction in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

Hypoxia-inducible factor pathway inhibition resolves tumor hypoxia and improves local tumor control after single-dose irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

Activation of AKT by hypoxia: a potential target for hypoxic tumors of the head and neck.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

Combination of vessel-targeting agents and fractionated radiation therapy: the role of the SDF-1/CXCR4 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

Microenvironment and radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

Molecular pathways: emerging pathways mediating growth, invasion, and metastasis of tumors progressing in an irradiated microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

A systematic analysis of experimental immunotherapies on tumors differing in size and duration of growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

Cyclophosphamide promotes chronic inflammation-dependent immunosuppression and prevents antitumor response in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

Targeting the PD1/PD-L1 axis in melanoma: biological rationale, clinical challenges and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

PD-1 blockade induces responses by inhibiting adaptive immune resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

Cancer immunotherapy and breaking immune tolerance: new approaches to an old challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

Adoptive cytotoxic T lymphocyte therapy triggers a counter-regulatory immunosuppressive mechanism via recruitment of myeloid-derived suppressor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

Suppression of Tregs by anti-glucocorticoid induced TNF receptor antibody enhances the antitumor immunity of interferon-α gene therapy for pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

Poxvirus-based vaccines for cancer immunotherapy: new insights from combined cytokines/co-stimulatory molecules delivery and "uncommon" strains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

Cell-based immunotherapy against gliomas: from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

Immunological monitoring of anticancer vaccines in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

Changes in the local tumor microenvironment in recurrent cancers may explain the failure of vaccines after surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2015.1059279

10.1586/14737140.2015.1059279

21 January 2018

Identifiers

DOI

1 reference

3 September 2017

1 reference